• Toho Holdings posted Q1 net sales of Yen 397.77 billion, up 5.84% year-on-year, while operating profit dropped 35.84% to Yen 2.47 billion.
• Net profit fell 29.76% to Yen 2.36 billion, as a 4.02% NHI drug price cut took effect following April’s drug price revision.
• Pharmaceutical wholesaling net sales rose 6.23% to Yen 384.57 billion, but operating profit slid 25.15% to Yen 3.11 billion on higher pharmaceutical purchase costs.
• Dispensing pharmacy net sales increased 1.45% to Yen 24.98 billion, while operating profit sank 38.59% to Yen 113 million due to fewer patient visits from longer-term prescriptions.
• Business updates included launching the 2026–2028 medium-term plan and investing via TOHO Ventures, with new tie-ups spanning AI antibody discovery and Japan logistics.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Toho Holdings Co. Ltd. published the original content used to generate this news brief on August 05, 2026, and is solely responsible for the information contained therein.